慢性类固醇使用与远端胰腺切除术后短期并发症无关联:倾向性匹配分析
基于美国国家手术质量改进计划数据库(2018-2024)的回顾性研究,分析6876例远端胰腺切除术患者,其中623例长期使用糖皮质激素。经倾向性匹配后比较438例激素组与876例非激素组,发现两组在胰瘘、主要并发症、次要并发症、死亡率、再入院及延长住院时间方面均无显著差异。多因素分析显示慢性类固醇使用并非独立不良预后因素。
要点
- 慢性糖皮质激素使用不增加远端胰腺切除术后短期并发症、胰瘘或死亡风险。
- 倾向性匹配后激素组与非激素组各项结局指标无显著差异。
- 慢性类固醇依赖不应视为远端胰腺切除术的禁忌证,但需谨慎解读。
核心结论
- 慢性糖皮质激素使用与远端胰腺切除术后短期并发症、胰瘘或死亡率增加无关。
- 慢性类固醇依赖不应被视为远端胰腺切除术的禁忌证,但结果需谨慎解读。
研究设计与样本
- 回顾性分析美国国家手术质量改进计划数据库(2018-2024)中行远端胰腺切除术的患者。
- 共纳入6876例患者,其中623例长期使用类固醇;经倾向性评分匹配后比较438例激素组与876例非激素组。
主要发现
- 多因素分析显示慢性类固醇使用并非任何不良结局的独立相关因素。
临床怎么用
- 对于长期使用糖皮质激素的患者,不应仅因类固醇依赖而排除远端胰腺切除术。
- 术前评估仍需个体化,结合患者整体状况综合决策。
局限性
- 无法评估类固醇使用的剂量-反应关系。
- 存在潜在残余混杂因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A national study analyzing the association between chronic steroid use and outcomes after pancreatic resection is lacking. This study aimed to evaluate the association between chronic glucocorticoid use and outcomes after distal pancreatectomy using a national database. METHODS: A retrospective analysis of patients undergoing distal pancreatectomy was performed using the National Surgical Quality Improvement Program database (2018-2024). In addition, we used propensity score matching to compare patients on chronic steroids with those who were not. The outcomes measured included 30-day complications and mortality, need for readmission, prolonged hospital stay, and pancreatic fistula. RESULTS: Of the 6,876 patients who underwent distal pancreatectomy, 623 were on chronic steroids. After propensity score matching, 438 patients in the steroid group and 876 patients in the nonsteroid group were compared. There were no significant differences in pancreatic fistula (23.7% vs 21.7%; P = .3), major complications (31.7% vs 30.1%; P = .1), minor complications (42.2% vs 41.6%; P = .6), mortality (3.4% vs 3.2%; P = .6), readmission (15.8% vs 14.7%; P = .3), or prolonged length of stay (11.4% vs 10.5%; P = .5). On multivariate analysis, chronic steroid use was not independently associated with any adverse outcomes. CONCLUSION: Chronic glucocorticoid use was not associated with increased short-term morbidity, pancreatic fistula, or mortality following distal pancreatectomy. These findings suggest that chronic steroid dependence should not be considered a contraindication to distal pancreatectomy, although the results should be interpreted with caution, given the inability to assess dose-response relationships and the potential for residual confounding.
引用
- Ganguli S, Gao JZ, Almeflehi MF, et al. Chronic steroid use is not associated with increased short-term morbidity after distal pancreatectomy: A propensity-matched analysis. Surgery. 2026. PMID: 42791100. doi:10.1016/j.surg.2026.110606
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。